Revisional Versus Primary Roux-en-Y Gastric Bypass: a Case Matched Analysis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Tarik Delko, University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT01771744
First received: January 16, 2013
Last updated: NA
Last verified: January 2013
History: No changes posted
  Purpose

This study compared revisional malabsorptive laparoscopic very very long limb gastric bypass (VVLL RYGB) with primary VVLL RYGB and tested the hypothesis that one staged revisional laparoscopic VVLL RYGB is a safe and effective procedure after failed restrictive gastric banding.


Condition
Effect of Revisional Surgery for Failed Gastric Banding

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Revisional Versus Primary Roux-en-Y Gastric Bypass: a Case Matched Analysis

Further study details as provided by University Hospital, Basel, Switzerland:

Primary Outcome Measures:
  • weight loss [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Complication rate [ Time Frame: early (30 days) and late (> 30 days) ] [ Designated as safety issue: No ]

Enrollment: 96
Study Start Date: January 2000
Study Completion Date: January 2013
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Morbidly obese patients
48 morbidly obese patients with revisional gastric bypass
48 morbidly obese patients
with primary gastric bypass

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

morbidly obese patients

Criteria

Inclusion Criteria:

  • Primary Gastric Bypass according to SMOB (Swiss group for the study of morbid obesity) Guidelines
  • Revisional Gastric Bypass after failed Gastric Banding

Exclusion Criteria:

  • According to SMOB Criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Tarik Delko, Dr, University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT01771744     History of Changes
Other Study ID Numbers: Revisional Limmi 1
Study First Received: January 16, 2013
Last Updated: January 16, 2013
Health Authority: Switzerland: Ethics committee of Zurich

ClinicalTrials.gov processed this record on August 18, 2014